Day Gain | ||
Gain | ||
Market Val | ||
Costs | ||
Cash | ||
Portfolio | ||
Realized | ||
Dividend |
Date | For | Estimate | Reported | Surprise | surprise % |
---|---|---|---|---|---|
2024-11-04 | 2024-09 | 0.06 | N/A | N/A | N/A |
2024-08-05 | 2024-06 | 0.05 | 0.06 | 0.01 | 20.00% |
2024-05-06 | 2024-03 | 0.02 | N/A | N/A | N/A |
2024-05-06 | 2024-03 | 0.02 | 0.05 | 0.03 | 150.00% |
2024-02-26 | 2023-12 | -0.02 | N/A | N/A | N/A |
2024-02-26 | 2023-12 | -0.02 | 0.01 | 0.03 | 150.00% |
Date | Firm | Action | From | To |
---|---|---|---|---|
2023-08-08 | Truist Securities | Upgrade | Hold | Hold |
2023-08-07 | Credit Suisse | Upgrade | Outperform | Outperform |
2023-07-27 | TD Cowen | Upgrade | Outperform | |
2023-06-14 | Tigress Financial | Upgrade | Buy | |
2023-05-29 | Piper Sandler | Upgrade | Neutral | Neutral |
2023-05-08 | B of A Securities | Upgrade | Buy |
Date | Name | Relation | Quantity | Description |
---|---|---|---|---|
2024-09-12 | BAIRD MELISSA | Chief Operating Officer | 630.17K | Conversion of Exercise of derivative security |
2024-09-16 | BECKLUND IRENE | Officer | 5.12K | Sale |
2024-09-16 | BOUGHTON SOLEIL | Officer | 176.95K | Sale |
2024-09-12 | CARROLL PATRICK HARRISON | Officer and Director | 211.94K | Conversion of Exercise of derivative security |
2024-09-16 | CHI MICHAEL | Officer | 193.98K | Sale |
2024-06-05 | COSGROVE DELOS M | Director | 54.40K | Conversion of Exercise of derivative security |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Group Inc | 13.70M | 128.76M | 6.76% |
2023-06-29 | Blackrock Inc. | 9.93M | 93.33M | 4.90% |
2023-06-29 | Institutional Venture Management XV, LLC | 7.71M | 72.47M | 3.80% |
2023-06-29 | Institutional Venture Management XVI, LLC | 7.71M | 72.47M | 3.80% |
2023-06-29 | Redpoint Management, Llc | 7.58M | 71.22M | 3.74% |
2023-06-29 | Marshall Wace LLP | 5.88M | 55.23M | 2.90% |
Report Date | Organization | Position | Value | Percentage |
---|---|---|---|---|
2023-06-29 | Vanguard Total Stock Market Index Fund | 4.52M | 42.49M | 2.23% |
2023-06-29 | Vanguard Small-Cap Index Fund | 3.63M | 34.13M | 1.79% |
2023-08-30 | iShares Russell 2000 ETF | 2.78M | 18.66M | 1.37% |
2023-06-29 | Vanguard Small-Cap Growth Index Fund | 2.08M | 19.55M | 1.03% |
2023-06-29 | Vanguard Extended Market Index Fund | 1.68M | 15.75M | 0.83% |
2023-07-30 | Franklin Strategic Series-Franklin Small Cap Growth Fund | 1.61M | 14.41M | 0.79% |
-
-
-
-
Can we talk about stocks in here and not emotions!
-
Kimbo why would you threaten to burn down wall street? Are you dumb or something. Stop it! If you are a so called software engineer you one of the dumbest on the planet!
-
You listen to the noise thats the issue.
-
Well lets find out this coming week bruv
-
-
Stop lying, post your subscription
-
-
Lovely article $40 is moderate I would say $50-55. Telemedicine is very powerful especially with upfront subscription. Most of the patients need atleast 3 months on weight loss injections to see any difference or even 7-15% weight reduction so they benefit from paying upfront
-
Insider selling shouldn’t really worry us at all they are small cap they tend to do that, there are many who still hold several shares. And several will still buy on this dip they know where this is going. I would like to see the company grow into telemedicine and expand on that as the market cap is largely untapped and has billions to offer.
-
Think big, think outside of the US, the potential for the stock is a 5 to 10 X. There really is no doubt about it. If you take time to research just how part of all telemedicine is then you will begin to realise that this is a gem of a Stock. In 10 to 20 years they will write articles about the stock about how those were held on, the early adopters are now multimillionaires
-
-
I know that HIMS is expanding INTO CANADA. I hope to see the expansion into EUROPE very soon. There’s a great market cap HERE for telemedicine. I have a great shortage of access to healthcare; I know that HIMS can bridge that gap
-
Two very large candles are closing that’s a dangerous sign as a short
-
-
3 US Insider Picks With Earnings Growth Up To 98%
news.google.com • -
Hims & Hers Acquisition: How Innovation Will Flourish
news.google.com • -
Hims & Hers Acquisition: How Innovation Will Flourish
news.google.com • -
How Is The Market Feeling About Hims & Hers Health?
news.google.com • -
Hims & Hers: Fear Surrounding GLP-1 Provides Another Opportunity
seekingalpha.com • -
The Globe and Mail
news.google.com • -
HIMS Stock Rises on Acquisition of Nivagen Pharmaceuticals
news.google.com • -
Hims & Hers Stock Pops After Massive Acquisition
news.google.com • -
Smart Money Is Betting Big In HIMS Options
news.google.com • -
Is Hims & Hers Health the Next Teladoc?
fool.com • -
Invest While You Can: Pullbacks on These 3 Stocks Won't Last Long
marketbeat.com • -
Is Hims & Hers Health Stock a Buy?
fool.com • -
Has Eli Lilly Destroyed Hims & Hers Upside?
247wallst.com • -
Is Hims & Hers Health Stock a Buy?
fool.com •